Skip to main content

Reclaiming Innovation in the Life Sciences: Reform FDA, Modernize its Culture

On April 8, 2013, Hudson Institute’s Initiative on Future Innovation convened a distinguished panel of experts from business, science, public health, law, and the academic world for an off-the-record workshop on a working draft of Reclaiming Innovation in the Life Sciences: Reform FDA, Modernize its Culture by Scott Gottlieb and Tevi Troy. Dr. Gottlieb is a physician and resident fellow at the American Enterprise Institute, and formerly served as deputy commissioner of the Food and Drug Administration. Mr. Troy is a visiting fellow at Hudson Institute and former deputy secretary of the U.S. Department of Health and Human Services. Reclaiming Innovation in the Life Sciences — which will be published in final form as the fourth in a series of major research papers by Hudson’s Innovation Initiative, and thereafter available for download on this page — is a careful analysis of procedural rules and regulatory guidelines governing FDA review of proposed new medical treatments and pharmaceutical products, and a prescription for major reform of that system in the interests of improved public health and economic efficiency.

Panel

Dr. Scott Gottlieb Author and Presenter

Resident Fellow, American Enterprise Institute; former deputy commissioner, FDA

Tevi Troy Author and Presenter

Hudson Visiting Fellow and former deputy secretary, U.S. Department of Health and Human Services

Christopher DeMuth Moderator

Hudson Distinguished Fellow and director, Initiative on Future Innovation

Margaret Anderson Discussant

FasterCures

Joe Grogan Discussant

Gilead Sciences

Brian Harvey Discussant

Pfizer Inc.

Tim Kane Discussant

Chief Economist, Hudson Institute

Coleen Klasmeier Discussant

Sidley Austin LLP

Hanns Kuttner Discussant

Hudson Senior Fellow

Dan Leonard Discussant

National Pharmaceutical Council

Lewis Libby Discussant

Hudson Senior Vice President

Jennifer Luray Discussant

BD

Michael Mandel Discussant

Progressive Policy Institute

Robert Popovian Discussant

Pfizer Inc.

David Tell Discussant

Hudson Senior Fellow and Director, Public Affairs & Special Projects

Marc Tessier-Lavigne Discussant

Rockefeller University

John P. Walters Discussant

Hudson Chief Operating Officer

Kenneth R. Weinstein Discussant

Hudson President & CEO

Margaret Whitehead Discussant

Hudson Board of Trustees

Benjamin Zycher Discussant

American Enterprise Institute

Experts

View all

Related Past Events

Crony Capitalism with Chinese Characteristics November 21st Event

The Economics of Net Neutrality October 1st Event

A Conversation with Representative Anna Eshoo September 18 Event